Back
NiSun International Enterprise Development Group 10K Form
Sell
8
NISN
NiSun International Enterprise Development Group
Last Price:
$5.16
Seasonality Move:
-16.55%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NISN News And Ratings
See the #1 stock for the next 7 days that we like better than NISN
NISN Financial Statistics
Sales & Book Value
Annual Sales: | $386.7M |
---|---|
Cash Flow: | $0 |
Price / Cash Flow: | 0.6 |
Annual Sales: | $51.76 |
Price / Book: | 0.12 |
Profitability
EPS (TTM): | 4.20000 |
---|---|
Net Income (TTM): | $16.6M |
Gross Margin: | $40M |
Return on Equity: | 8.22% |
Return on Assets: | 5.49% |
NiSun International Enterprise Development Group Earnings Forecast
Key NiSun International Enterprise Development Group Financial Ratios
-
The Gross Profit Margin over the past 11 years for NISN is 10.34%.
-
The Selling, General & Administrative Expenses for NISN have been equal to 3.20% of Gross Profit Margin.
-
The Research & Development expenses have been 0.28% of Revenue.
-
The Interest Expense is 5.84% of Operating Income.
-
The Net Earning history of NISN is 4.55% of Total Revenues.
-
Per Share Earnings over the last 11 years have been positive in 5 years.
NiSun International Enterprise Development Group Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Software |
Sector: | Information Technology |
Current Symbol: | NISN |
Website: | fintaike.com |
Debt
Debt-to-Equity Ratio: | 0.01 |
---|---|
Current Ratio: | 4.22 |
Quick Ratio: | 2.08 |
Price-to-Earnings
Trailing P/E Ratio: | 1.17 |
---|---|
Forward P/E Ratio: | 0 |
NISN Technical Analysis vs Fundamental Analysis
Sell
8
NiSun International Enterprise Development Group (NISN)
is a Sell
Is NiSun International Enterprise Development Group a Buy or a Sell?
-
NiSun International Enterprise Development Group stock is rated a SellThe current NiSun International Enterprise Development Group [NISN] share price is $5.23. The Score for NISN is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.